EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 2, 2012, Pages 235-240

  Rezvani, Katayoun ^a   Kanfer, Edward J ^a   Marin, David ^a   Gabriel, Ian ^a   Rahemtulla, Amin ^a   Taylor, Alexandra ^a   MacDonald, Donald ^a   Dazzi, Francesco ^a   Milojkovic, Dragana ^a   Foroni, Letizia ^a   Pavlu, Jiri ^a   Sargent, Jeremy ^a   Le Dieu, Rifca ^a   Goldman, John M ^a   Apperley, Jane ^a   Szydlo, Richard ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Autologous stem cell transplant; Leukemia; Lymphoma; Myeloma; Risk score; Second stem cell transplant

Indexed keywords

ACUTE LEUKEMIA; ADULT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; DISEASE SEVERITY; DONOR; EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION RISK SCORE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84855599610     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.06.010     Document Type: Article

References (30)

1. Kishi K., Takahashi S., Gondo H., et al. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant 1997, 19:461-466.
2. Mehta J., Powles R., Treleaven J., et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplant 1997, 19:709-719.
3. Blau I.W., Basara N., Bischoff M., et al. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant. Bone Marrow Transplant 2000, 25:41-45.
4. Keil F., Prinz E., Kalhs P., et al. Treatment of leukemic relapse after allogeneic stem cell transplantation with cytoreductive chemotherapy and/or immunotherapy or second transplants. Leukemia 2001, 15:355-361.
5. Tomonari A., Iseki T., Ooi J., et al. Second allogeneic hematopoietic stem cell transplantation for leukemia relapse after first allogeneic transplantation: outcome of 16 patients in a single institution. Int J Hematol 2002, 75:318-323.
6. Meshinchi S., Leisenring W.M., Carpenter P.A., et al. Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia. Biol Blood Marrow Transplant 2003, 9:706-713.
7. Eapen M., Giralt S.A., Horowitz M.M., et al. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant 2004, 34:721-727.
8. Duus J.E., Stiff P.J., Choi J., et al. Second allografts for relapsed hematologic malignancies: feasibility of using a different donor. Bone Marrow Transplant 2005, 35:261-264.
9. Pollyea D.A., Artz A.S., Stock W., et al. Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2007, 40:1027-1032.
10. Hill B.T., Bolwell B.J., Rybicki L., et al. Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants. Biol Blood Marrow Transplant 2010, 16:1738-1746.
11. Arfons L.M., Tomblyn M., Rocha V., Lazarus H.M. Second hematopoietic stem cell transplantation in myeloid malignancies. Curr Opin Hematol 2009, 16:112-123.
12. Radich J.P., Gooley T., Sanders J.E., et al. Second allogeneic transplantation after failure of first autologous transplantation. Biol Blood Marrow Transplant 2000, 6:272-279.
13. Ringden O., Labopin M., Gorin N.C., et al. The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2000, 25:1053-1058.
14. Bosi A., Bacci S., Miniero R., et al. Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO). Leukemia 1997, 11:420-424.
15. Gratwohl A., Hermans J., Goldman J.M., et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 1998, 352:1087-1092.
16. Gratwohl A., Stern M., Brand R., et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer 2009, 115:4715-4726.
17. Savani B.N., Mielke S., Reddy N., et al. Management of relapse after allo-SCT for AML and the role of second transplantation. Bone Marrow Transplant 2009, 44:769-777.
18. Thakar M.S., Forman S.J. ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?. Hematology 2009, 414-418.
19. Kishi K., Takahashi S., Gondo H., et al. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant 1997, 19:461-466.
20. Mehta J., Powles R., Treleaven J., et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplant 1997, 19:709-719.
21. Blau I.W., Basara N., Bischoff M., et al. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant. Bone Marrow Transplant 2000, 25:41-45.
22. Keil F., Prinz E., Kalhs P., et al. Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants. Leukemia 2001, 15:355-361.
23. Tomonari A., Iseki T., Ooi J., et al. Second allogeneic hematopoietic stem cell transplantation for leukemia relapse after first allogeneic transplantation: outcome of 16 patients in a single institution. Int J Hematol 2002, 75:318-323.
24. Meshinchi S., Leisenring W.M., Carpenter P.A., et al. Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia. Biol Blood Marrow Transplant 2003, 9:706-713.
25. Eapen M., Giralt S.A., Horowitz M.M., et al. Second transplant foracute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant 2004, 34:721-727.
26. Duus J.E., Stiff P.J., Choi J., et al. Second allografts for relapsed hematologic malignancies: feasibility of using a different donor. Bone Marrow Transplant 2005, 35:261-264.
27. Pollyea D.A., Artz A.S., Stock W., et al. Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2007, 40:1027-1032.
28. Michallet M., Tanguy M.L., Socié G., et al. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de Moelle (SFGM). Br J Haematol 2000, 108:400-407.
29. Bosi A., Laszlo D., Labopin M., et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol 2001, 19:3675-3684.
30. Shaw B.E., Mufti G.J., Mackinnon S., et al. Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplant 2008, 42:783-789.